Overview
Curtis Miyamoto is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Miyamoto is highly rated in 10 conditions, according to our data. His top areas of expertise are Prostate Cancer, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer.
His clinical research consists of co-authoring 19 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3401 N Broad St, Philadelphia, PA 19140
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Abramson Cancer Center Penn Presbyterian
Keith Cengel is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Cengel is highly rated in 38 conditions, according to our data. His top areas of expertise are Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Cengel is currently accepting new patients.
Radiation Oncology At Thomas Jefferson University Hospital
Wenyin Shi is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Shi is highly rated in 33 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Mycosis Fungoides, and Gamma Knife Radiosurgery. Dr. Shi is currently accepting new patients.
Penn Radiation Oncology Perelman-Concourse Level
Jeffrey Bradley is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Bradley is highly rated in 26 conditions, according to our data. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Thymic Epithelial Tumor. Dr. Bradley is currently accepting new patients.
Frequently Asked Questions about Dr. Curtis T. Miyamoto
How do I make an appointment with Dr. Curtis T. Miyamoto?
You can book an appointment with Dr. Curtis T. Miyamoto by calling their office at 215-707-5030. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Curtis T. Miyamoto a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Curtis T. Miyamoto is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Curtis T. Miyamoto specialize in?
While Dr. Curtis T. Miyamoto is a Radiation Oncology, they have specific expertise in Prostate Cancer, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Curtis T. Miyamoto participate in research or clinical trials?
Yes. Dr. Curtis T. Miyamoto has published 19 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Curtis T. Miyamoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Curtis T. Miyamoto accept my insurance?
Dr. Curtis T. Miyamoto accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 215-707-5030 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Miyamoto isDistinguished. Learn about Familial Prostate Cancer.
- Laryngeal CancerDr. Miyamoto isDistinguished. Learn about Laryngeal Cancer.
- Posterior Fossa TumorDr. Miyamoto isDistinguished. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Miyamoto isDistinguished. Learn about Primitive Neuroectodermal Tumor (PNET).
- Prostate CancerDr. Miyamoto isDistinguished. Learn about Prostate Cancer.
- Advanced
- Breast CancerDr. Miyamoto isAdvanced. Learn about Breast Cancer.
- Lung CancerDr. Miyamoto isAdvanced. Learn about Lung Cancer.
- Metastatic Brain TumorDr. Miyamoto isAdvanced. Learn about Metastatic Brain Tumor.
- Pleuropulmonary BlastomaDr. Miyamoto isAdvanced. Learn about Pleuropulmonary Blastoma.
- Throat CancerDr. Miyamoto isAdvanced. Learn about Throat Cancer.
- Experienced
- Acoustic NeuromaDr. Miyamoto isExperienced. Learn about Acoustic Neuroma.
- ALK-Positive Non-Small Cell Lung CancerDr. Miyamoto isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Miyamoto isExperienced. Learn about Anal Cancer.
- Arteriovenous MalformationDr. Miyamoto isExperienced. Learn about Arteriovenous Malformation.
- AstrocytomaDr. Miyamoto isExperienced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)Dr. Miyamoto isExperienced. Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).